0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Subdermal Contraceptive Implants - Global Strategic Business Report

  • PDF Icon

    Report

  • 74 Pages
  • June 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 6071487
Description Jump to:
The global market for Subdermal Contraceptive Implants was estimated at US$1.1 Billion in 2024 and is projected to reach US$1.6 Billion by 2030, growing at a CAGR of 6.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Subdermal Contraceptive Implants market.

Global Subdermal Contraceptive Implants Market - Key Trends & Drivers Summarized

Why Are Subdermal Implants Gaining Favor Over Traditional Contraceptives?

Subdermal contraceptive implants are witnessing a notable surge in global adoption, largely due to the growing preference for long-acting reversible contraceptives (LARCs) among women of reproductive age. Unlike daily oral contraceptives or short-term methods like patches and injections, subdermal implants offer protection for three to five years with a single insertion, significantly reducing the risk of user error and increasing overall efficacy. The market is benefitting from increased awareness and education about reproductive rights and contraception options, particularly in developing regions where access to healthcare is improving. Furthermore, public health initiatives by organizations such as the World Health Organization (WHO), UNFPA, and USAID are actively promoting the use of implants in regions with high fertility rates and limited access to contraceptive resources. Compared to intrauterine devices (IUDs), subdermal implants are less invasive and do not require uterine placement, making them a preferred option for women who may not have given birth. The minimal maintenance, discreet nature, and reversible function of implants are reshaping how contraception is viewed, shifting the narrative toward convenience, autonomy, and long-term planning. As a result, these devices are not only finding favor in urban, educated populations but also penetrating rural and underserved areas via government and NGO-supported programs.

How Are Healthcare Policies and Global Campaigns Accelerating Adoption?

Government healthcare policies and international campaigns are playing a central role in accelerating the adoption of subdermal contraceptive implants, especially in regions with unmet needs for family planning. In low- and middle-income countries (LMICs), the push toward universal access to reproductive healthcare under frameworks like the Sustainable Development Goals (SDGs) has spurred large-scale procurement and subsidized distribution of contraceptive implants. Initiatives such as the FP2030 partnership and global donor alliances have secured favorable pricing agreements with manufacturers, ensuring implants are affordable or free to millions of women worldwide. National governments, particularly in Sub-Saharan Africa and Southeast Asia, are integrating subdermal implants into public health programs and providing training for community health workers to increase outreach and trust. Meanwhile, in developed countries, policy shifts around women`s health, gender equity, and reproductive autonomy have led to insurance coverage for LARCs, boosting their uptake among teenagers and young adults. School-based and clinic-based awareness campaigns, alongside expanding access via telehealth and pharmacy-based models, are ensuring that information and services reach broader populations. These coordinated policy and advocacy efforts are reducing stigma, improving access, and ensuring that women can make informed choices about their reproductive health - factors that are directly driving growth in the subdermal contraceptive implant market.

Are Technological Innovations Enhancing Device Design and Acceptance?

Yes, technological innovations in implant design and insertion methods are making subdermal contraceptive implants more appealing, safer, and easier to use for both healthcare providers and patients. The market is seeing a shift toward next-generation implants with thinner, more flexible rods that are easier to insert and remove with minimal discomfort. Advancements in bioresorbable materials and hormone release mechanisms are allowing for more consistent and controlled delivery of active agents like etonogestrel, thereby improving efficacy and reducing side effects. Device manufacturers are also developing smart insertion kits that reduce procedural time and complexity, further encouraging healthcare providers to offer the method. Some research efforts are focused on digital or trackable implants, incorporating microchips or radio-frequency identification (RFID) tags that can store dosing information and facilitate patient follow-up. Additionally, there's an increased emphasis on culturally sensitive packaging and instruction materials, improving acceptance in diverse sociocultural contexts. As removal continues to be a concern in some regions, efforts are being made to ensure training programs focus equally on insertion and safe, timely removal. All these technological strides are making the devices more user-centric, thereby enhancing patient satisfaction and expanding market reach across different healthcare ecosystems.

What's Behind the Rising Demand for These Implants Around the World?

The growth in the subdermal contraceptive implants market is driven by several factors rooted in reproductive health trends, healthcare access, demographic shifts, and medical innovation. The rising global demand for effective, low-maintenance contraception is a major driver, particularly among women seeking autonomy in family planning without daily adherence challenges. Younger populations in both urban and rural areas are showing increased interest in discreet, long-term contraceptive solutions, and implants fit that profile well. Growing awareness of the health and economic benefits of delayed or spaced pregnancies, supported by data and educational campaigns, is influencing more women to choose long-acting methods. Furthermore, the proliferation of government and NGO-supported reproductive health programs is making these implants more accessible and affordable across a wider range of socioeconomic groups. From a healthcare provider standpoint, implants are now favored due to simplified administration protocols, shorter procedure times, and fewer follow-up requirements compared to alternatives. Technological refinement in the devices themselves - such as longer duration, improved hormone delivery, and easier removability - is reinforcing consumer trust. Regulatory bodies worldwide are also fast-tracking approval and adoption of new models, recognizing their public health value. Lastly, shifting cultural attitudes toward family planning and increased female participation in education and the workforce are reinforcing the importance of reproductive autonomy, making subdermal implants a compelling solution in modern contraceptive care.

Scope of Study:

The report analyzes the Subdermal Contraceptive Implants market in terms of units by the following Segments, and Geographic Regions/Countries:
  • Segments: Product (Etonogestrel Implant, Levonorgestrel Implant); Distribution Channel (Hospital, Gynecology Clinics, Community Health Care Centers, Others)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Etonogestrel Implant segment, which is expected to reach US$1.1 Billion by 2030 with a CAGR of a 7.9%. The Levonorgestrel Implant segment is also set to grow at 4.6% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $296.0 Million in 2024, and China, forecasted to grow at an impressive 10.8% CAGR to reach $337.7 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Subdermal Contraceptive Implants Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Subdermal Contraceptive Implants Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Subdermal Contraceptive Implants Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Allergan plc, Baxter International Inc., Bayer AG, Bayer Schering Pharma, Conceptus Inc. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 44 companies featured in this Subdermal Contraceptive Implants market report include:

  • Allergan plc
  • Baxter International Inc.
  • Bayer AG
  • Bayer Schering Pharma
  • Conceptus Inc.
  • Contraline, Inc.
  • DKT International
  • DKT WomanCare
  • Eli Lilly and Company
  • FHI 360
  • Gerresheimer AG
  • HRA Pharma
  • Karex Industries
  • KESSEL medintim GmbH
  • Leiras Oy
  • Mayer Laboratories
  • Merck & Co., Inc.
  • Novartis AG
  • Organon
  • Pfizer Inc.
  • Population Council
  • Reckitt Benckiser Group plc
  • Sandoz International GmbH
  • Schott AG
  • Shanghai Dahua Pharmaceutical Co., Ltd.
  • SMB Corporation
  • Teva Pharmaceutical Industries Ltd.
  • The Female Health Company
  • Theramex
  • Wyeth Pharmaceuticals

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

  • Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
  • Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
  • Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
  • Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
  • Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
  • Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
  • Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Subdermal Contraceptive Implants - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Focus on Long-Acting Reversible Contraceptives (LARCs) Propels Growth in Subdermal Implant Adoption
Increased Government and NGO-Led Family Planning Initiatives Expand the Addressable Market in Emerging Economies
Shift Toward Female-Centric and Autonomous Contraceptive Methods Strengthens the Business Case for Implants
Affordability and High Efficacy of Subdermal Implants Drive Demand in Public Health and Low-Income Settings
Growing Acceptance of Minimal-Maintenance Birth Control Solutions Accelerates Demand Across Age Groups
Technological Advancements in Implant Materials and Insertion Devices Spur Innovation and Safety Improvements
Healthcare Provider Training and Outreach Programs Drive Adoption in Underserved and Rural Populations
Changing Social Norms and Awareness Campaigns Generate Demand for Discreet and Long-Term Contraception
Rising Insurance Coverage and Reimbursement Support Strengthens Uptake in Developed Markets
Expanded Use in Postpartum and Adolescent Contraception Creates New Opportunities for Market Penetration
Demand for Reversible and Fertility-Preserving Options Spurs Preference for Implantable Devices
Integration of Contraceptive Counseling into Primary Healthcare Systems Supports Long-Term Market Growth
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Subdermal Contraceptive Implants Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Subdermal Contraceptive Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for Subdermal Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Etonogestrel Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Etonogestrel Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for Etonogestrel Implant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Levonorgestrel Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Levonorgestrel Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for Levonorgestrel Implant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for Hospital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Gynecology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Gynecology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 16: World 15-Year Perspective for Gynecology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Community Health Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Community Health Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 19: World 15-Year Perspective for Community Health Care Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 22: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 23: USA Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 24: USA Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 25: USA 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
TABLE 26: USA Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 27: USA Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 28: USA 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
CANADA
TABLE 29: Canada Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 30: Canada Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 31: Canada 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
TABLE 32: Canada Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 33: Canada Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 34: Canada 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
JAPAN
Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 35: Japan Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 36: Japan Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 37: Japan 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
TABLE 38: Japan Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 39: Japan Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 40: Japan 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
CHINA
Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 41: China Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 42: China Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 43: China 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
TABLE 44: China Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 45: China Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 46: China 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
EUROPE
Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 47: Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Subdermal Contraceptive Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 49: Europe 15-Year Perspective for Subdermal Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 52: Europe 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
TABLE 53: Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 54: Europe Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 55: Europe 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
FRANCE
Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 56: France Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 57: France Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 58: France 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
TABLE 59: France Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 60: France Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 61: France 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
GERMANY
Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 62: Germany Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 63: Germany Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 64: Germany 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
TABLE 65: Germany Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 66: Germany Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 67: Germany 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
ITALY
TABLE 68: Italy Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 69: Italy Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 70: Italy 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
TABLE 71: Italy Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 72: Italy Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 73: Italy 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
UNITED KINGDOM
Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 74: UK Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 75: UK Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 76: UK 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
TABLE 77: UK Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 78: UK Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 79: UK 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
SPAIN
TABLE 80: Spain Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 81: Spain Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 82: Spain 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
TABLE 83: Spain Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 84: Spain Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 85: Spain 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
RUSSIA
TABLE 86: Russia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 87: Russia Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 88: Russia 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
TABLE 89: Russia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 90: Russia Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 91: Russia 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 93: Rest of Europe Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 94: Rest of Europe 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 96: Rest of Europe Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 97: Rest of Europe 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Subdermal Contraceptive Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 100: Asia-Pacific 15-Year Perspective for Subdermal Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 103: Asia-Pacific 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 105: Asia-Pacific Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 106: Asia-Pacific 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
AUSTRALIA
Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINA
BRAZIL
MEXICO
REST OF LATIN AMERICA
MIDDLE EAST
Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRAN
ISRAEL
SAUDI ARABIA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
AFRICA
Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Allergan plc
  • Baxter International Inc.
  • Bayer AG
  • Bayer Schering Pharma
  • Conceptus Inc.
  • Contraline, Inc.
  • DKT International
  • DKT WomanCare
  • Eli Lilly and Company
  • FHI 360
  • Gerresheimer AG
  • HRA Pharma
  • Karex Industries
  • KESSEL medintim GmbH
  • Leiras Oy
  • Mayer Laboratories
  • Merck & Co., Inc.
  • Novartis AG
  • Organon
  • Pfizer Inc.
  • Population Council
  • Reckitt Benckiser Group plc
  • Sandoz International GmbH
  • Schott AG
  • Shanghai Dahua Pharmaceutical Co., Ltd.
  • SMB Corporation
  • Teva Pharmaceutical Industries Ltd.
  • The Female Health Company
  • Theramex
  • Wyeth Pharmaceuticals

Table Information

Report AttributeDetails
No. of Pages74
PublishedJune 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.1 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.6 Billion
Compound Annual Growth Rate6.7%
Regions CoveredGlobal

Related Topics

Related Reports

Subdermal Contraceptive Implants - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Subdermal Contraceptive Implants - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
EUR$3,750USDGBP
Subdermal Contraceptive Implants Market Size, Share & Trends Analysis Report by Product (Etonogestrel Implant, Levonorgestrel Implant), Distribution Channel, and Region with Growth Forecasts, 2025-2030 - Product Image

Subdermal Contraceptive Implants Market Size, Share & Trends Analysis Report by Product (Etonogestrel Implant, Levonorgestrel Implant), Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • 80 Pages
  • Global
From
EUR$5,950USDGBP
Contraceptives Market Report 2025 - Product Image

Contraceptives Market Report 2025

  • Report
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Contraceptives - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Contraceptives - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
EUR$3,750USDGBP
Contraceptive Drugs and Devices Market Size, Share & Trends Analysis Report by Product (Contraceptive Drugs (Pills, Patch, Injectable), Contraceptive Devices), and Region with Growth Forecasts, 2025-2030 - Product Image

Contraceptive Drugs and Devices Market Size, Share & Trends Analysis Report by Product (Contraceptive Drugs (Pills, Patch, Injectable), Contraceptive Devices), and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
EUR$5,950USDGBP
Copyright © 2002-2025 Research and Markets. All Rights Reserved.
This website uses cookies to ensure you get the best experience. Learn more